Solid Biosciences Inc.
SLDB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $163 | $122 | $46 | $187 |
| - Cash | $80 | $74 | $155 | $119 |
| + Debt | $24 | $26 | $29 | $2 |
| Enterprise Value | $107 | $74 | -$81 | $70 |
| Revenue | $0 | $0 | $8 | $14 |
| % Growth | – | -100% | -40.6% | – |
| Gross Profit | -$2 | -$3 | $8 | $14 |
| % Margin | – | – | 100% | 100% |
| EBITDA | -$122 | -$93 | -$97 | -$69 |
| % Margin | – | – | -1,196.8% | -508.7% |
| Net Income | -$125 | -$96 | -$86 | -$72 |
| % Margin | – | – | -1,062.3% | -530% |
| EPS Diluted | -3.06 | -4.83 | -10.1 | -10.14 |
| % Growth | 36.6% | 52.2% | 0.4% | – |
| Operating Cash Flow | -$100 | -$94 | -$98 | -$78 |
| Capital Expenditures | -$1 | -$2 | -$3 | -$1 |
| Free Cash Flow | -$101 | -$96 | -$101 | -$79 |